|
Real-time
Euronext Paris
16:55:00 02/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 0.0750 EUR | 0.00% |
|
-26.47% | -43.61% |
| 10-29 | IntegraGen SA Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 10-12 | ABL Texcell Diagnostics to Acquire French Biotech Company IntegraGen | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Diagnostics & Testing
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 554K | - | - | - | - | - |
| 62.23B | |||||
| 54.92B | |||||
| 55.26B | |||||
| 42.59B | |||||
| 41.08B |
- Stock Market
- Stocks
- ALINT Stock
- Charts IntegraGen
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
